MENU
+Compare
LUCD
Stock ticker: NASDAQ
AS OF
Jul 25, 04:59 PM (EDT)
Price
$1.10
Change
+$0.01 (+0.91%)
Capitalization
42.94M

LUCD Lucid Diagnostics Forecast, Technical & Fundamental Analysis

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more

LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LUCD with price predictions
Jul 24, 2025

LUCD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for LUCD turned positive on July 11, 2025. Looking at past instances where LUCD's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LUCD's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

LUCD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where LUCD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on July 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LUCD entered a downward trend on July 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LUCD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (35.088) is normal, around the industry mean (24.694). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (15.314) is also within normal values, averaging (43.573).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LUCD is expected to report earnings to fall 30.00% to -11 cents per share on August 18

Lucid Diagnostics LUCD Stock Earnings Reports
Q2'25
Est.
$-0.11
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.20
The last earnings report on May 14 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 234.00K shares outstanding, the current market capitalization sits at 42.94M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
70
Web
https://www.luciddx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACDC8.190.44
+5.68%
ProFrac Holding Corp
LRCX97.780.68
+0.70%
Lam Research Corp
REYN22.17-0.13
-0.58%
Reynolds Consumer Products
VSTM5.29-0.06
-1.12%
Verastem
RFL2.11-0.04
-1.86%
Rafael Holdings

LUCD and Stocks

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-1.79%
NOTV - LUCD
32%
Poorly correlated
+4.89%
FEMY - LUCD
31%
Poorly correlated
+4.37%
CRL - LUCD
26%
Poorly correlated
+5.45%
NTRA - LUCD
23%
Poorly correlated
+2.35%
BWAY - LUCD
23%
Poorly correlated
-0.42%
More